Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis
Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis
Theratechnologies宣佈已與ionis pharmaceuticals達成協議，許可ionis研發的兩種調查用RNA靶向藥物。
Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis
Theratechnologies宣佈已與ionis pharmaceuticals達成協議，授權使用由ionis pharmaceuticals開發的兩種研究中的RNA靶向藥物。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間